Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Home
Glenmark Pharmaceuticals Limited
Press Release Jan 20 2022
Business
Jan 20 2022
3 min read

Press Release Jan 20 2022

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 20, 2022, titled "Glenmark Specialty S.A. and Lotus International Pte. Ltd. enter into Exclusive Licensing Agreement for commercializing Ryaltris Nasal Spray in for Singapore, Hong Kong and Vietnam".

View Attachment